Video-Thoracoscopic Management of Postpneumonectomy Empyema

Domenico Galetta1, Lorenzo Spaggiari1,2

  • 1Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy.

Abstract

Insights

Video-thoracoscopic debridement is an effective minimally invasive treatment for postpneumonectomy empyema (PPE), even with minor bronchopleural fistulas (BPF). This approach offers a safe and efficient alternative to aggressive treatments for selected patients.

Area of Science:

  • Thoracic Surgery
  • Minimally Invasive Procedures
  • Infectious Disease Management

Background:

  • Postpneumonectomy empyema (PPE) is a severe complication following lung removal surgery.
  • Traditional treatments for PPE involve aggressive irrigation and material removal.
  • Minimally invasive options may offer satisfactory outcomes in select cases.

Purpose of the Study:

  • To evaluate the efficacy and safety of video-thoracoscopic surgery for treating postpneumonectomy empyema.
  • To assess outcomes in patients with and without bronchopleural fistula (BPF).

Main Methods:

  • Retrospective review of 18 patients with PPE treated via video-thoracoscopic approach.
  • All patients underwent chest tube drainage and thoracoscopic debridement.
  • Patient data included pneumonectomy indication, BPF status, and procedural details.

Main Results:

  • No mortality or morbidity associated with the video-thoracoscopic procedure.
  • Average debridement time was 56 minutes; median postoperative stay was 7 days.
  • No recurrent empyema observed during a median follow-up of 41.5 months.

Conclusions:

  • Video-thoracoscopic debridement is a viable and efficient treatment for PPE.
  • The approach is effective even in the presence of minimal bronchopleural fistulas.
  • Minimally invasive thoracoscopy provides a safe and effective treatment option for selected PPE patients.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
438
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
220
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
173
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
657
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
545
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
297